Titan Pharmaceuticals, Inc. Stock Price

NasdaqCM:TTNP Community·US$6.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

TTNP Share Price Performance

US$4.61

1.33 (40.55%)

US$4.61

1.33 (40.55%)

US$4.61

Thu, 15 Jan 26

Share Pricen/a

TTNP Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks

1 Reward

View Full Analysis

Titan Pharmaceuticals, Inc. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -2.11
: 0%
: 0%
: 0%

View Full Analysis

About TTNP

Founded: 1991
Employees: 4
CEO: Weei Chay
WebsiteView website: www.titanpharm.com

Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

Recent TTNP News & Updates

Recent updates

No updates

Titan Pharmaceuticals, Inc. Competitors

Titan Pharmaceuticals, Inc. Stock Price

TTNP Share Price Performance

TTNP Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Titan Pharmaceuticals, Inc. Key Details

About TTNP

Recent TTNP News & Updates

Titan Pharmaceuticals, Inc. announced that it has received $0.6 million in funding from Blue Harbour Asset Management L.L.C

Titan Pharmaceuticals, Inc., Annual General Meeting, Jun 16, 2025

Titan Pharmaceuticals Receives Nasdaq Non-Compliance Notice Regarding Listing Rules 5620(a) and 5810(c)(2)(G)

Recent updates

Titan Pharmaceuticals, Inc. Competitors

Phio Pharmaceuticals

Gelteq

Edesa Biotech

Rize Oncology